CORRECTION article

Front. Immunol., 14 March 2022

Sec. Inflammation

Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.881277

Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages

  • 1. Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  • 2. Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China

  • 3. Department of Dermatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China

  • 4. Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China

In the original article, there was a mistake in Figure 1 as published. In Figure 1A, the y-axis of the top graph was labelled “CD68 staining score”, when it should have been labelled “TLR2 staining score”. The corrected Figure 1 appears below.

Figure 1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

rosacea, carvedilol, macrophage, TLR2, KLK5, cathelicidin

Citation

Zhang J, Jiang P, Sheng L, Liu Y, Liu Y, Li M, Tao M, Hu L, Wang X, Yang Y, Xu Y and Liu W (2022) Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages. Front. Immunol. 13:881277. doi: 10.3389/fimmu.2022.881277

Received

22 February 2022

Accepted

28 February 2022

Published

14 March 2022

Volume

13 - 2022

Edited and reviewed by

Jingyuan Wan, Chongqing Medical University, China

Updates

Copyright

*Correspondence: Yang Xu, ; Wentao Liu,

†These authors have contributed equally to this work

This article was submitted to Inflammation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics